報價延遲最少15分鐘:2025/07/07 03:07 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
135.44 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.83/7.93
|
|
企業價值
4.93B
|
| 資產負債 |
|
每股賬面淨值
80.76
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
2.38B
|
|
每股收益
91.39
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 03:07 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically. |